RVTY raises margin guidance on AI-driven demand and cost initiatives
RVTY cites AI-driven demand for high-content screening and software innovation, plus robust diagnostics and reproductive health growth. It also says a tuck-in reagents acquisition supports the reagents business, and raises margin guidance on execution and cost initiatives.